CPIVC NEWS

AIM Vaccine's 20-valent pneumococcal conjugate vaccine receives clinical approval from China's NMPA

2026-06-01

Link: https://www.prnewswire.com/apac/news-releases/aim-vaccines-20-valent-pneumococcal-conjugate-vaccine-receives-clinical-approval-upgraded-iterative-major-product-expected-to-seize-domestic-opportunities-302664501.html